Research Paper Volume 13, Issue 10 pp 13876—13897
Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer
Figure 12. Validation of prognosis risk model. (A) Kaplan-Meier curves for OS time of patients with expression of NFAT2 in clinical study GSE100926. (B) Patients data from GSE100926 were divided by risk score into a high risk and a low risk groups. OS between two risk groups were analyzed and compared by Kaplan-Meier analysis. (C) 1-3-5 years ROC curves in GSE100926. The abscissa represents sensitivity, and the ordinate represents specificity. (D–F) The calibration curve for predicting 1-3-5 years OS for patients with BLCA. The Y-axis represents actual survival, as measured by K-M analysis, and the X-axis represents the nomogram-predicted survival (P<0.05). (G) The expression profiles of the NFAT2 in the normal bladder tissue and bladder specimens. Images were taken from the HPA.